| Item Type | Name |
|
Academic Article
|
Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.
|
|
Academic Article
|
A 9-year experience with 126 pancreas transplants with portal enteric drainage.
|
|
Academic Article
|
Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era.
|
|
Academic Article
|
A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
|
|
Academic Article
|
A multicenter, open-label, comparative trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: 6-month interim analysis.
|
|
Academic Article
|
Improving results in solitary pancreas transplantation with portal-enteric drainage and thymoglobulin induction.
|
|
Academic Article
|
Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.
|
|
Academic Article
|
Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
|
|
Academic Article
|
African-American ethnicity is no longer a risk factor for early adverse outcomes in simultaneous kidney-pancreas transplantation with contemporary immunosuppression.
|
|
Academic Article
|
Does surgical technique influence outcomes after simultaneous kidney-pancreas transplantation?
|
|
Academic Article
|
One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumab.
|
|
Academic Article
|
Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
|
|
Academic Article
|
Evaluation of an immunosuppressant side effect instrument.
|
|
Academic Article
|
Successful simultaneous kidney-pancreas transplantation from extreme donors.
|
|
Academic Article
|
Experience with alternate-day thymoglobulin induction in pancreas transplantation with portal-enteric drainage.
|
|
Academic Article
|
Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantation.
|
|
Academic Article
|
Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipients.
|
|
Academic Article
|
Analysis of bacteremia after pancreatic transplantation with enteric drainage.
|
|
Academic Article
|
OKT3 salvage therapy in a quadruple immunosuppressive protocol in cadaveric renal transplantation.
|
|
Academic Article
|
Management of leukopenia in kidney and pancreas transplant recipients.
|
|
Academic Article
|
Clinical results in liver transplantation using UW solution for extended preservation.
|
|
Academic Article
|
Perioperative infection in liver transplant recipients under a quadruple immunosuppressive protocol.
|
|
Academic Article
|
The APOL1 gene and allograft survival after kidney transplantation.
|
|
Academic Article
|
Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression.
|
|
Academic Article
|
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
|
|
Academic Article
|
Surgical complications in solitary pancreas and combined pancreas-kidney transplantations.
|
|
Academic Article
|
A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients.
|
|
Academic Article
|
Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. The FK/MMF Multi-Center Study Group.
|
|
Academic Article
|
Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.
|
|
Academic Article
|
Long-term outcomes in simultaneous kidney-pancreas transplant recipients.
|
|
Academic Article
|
Immunosuppression in pancreas transplantation: progress, problems and perspective.
|
|
Academic Article
|
Review of immunosuppressive usage in pancreas transplantation.
|
|
Academic Article
|
Lipids increase after solitary pancreas transplantation.
|
|
Academic Article
|
Surgical complications after pancreas transplantation with portal-enteric drainage.
|
|
Academic Article
|
Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis.
|
|
Academic Article
|
Simultaneous kidney-pancreas transplantation without antilymphocyte induction.
|
|
Academic Article
|
Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage.
|
|
Academic Article
|
Fate of the pancreas after asynchronous kidney loss in patients undergoing simultaneous kidney/pancreas transplantation.
|
|
Academic Article
|
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.
|
|
Academic Article
|
A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage.
|
|
Academic Article
|
Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
|
|
Academic Article
|
Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation.
|
|
Academic Article
|
Immunosuppressant side effect profile does not differ between organ transplant types.
|
|
Academic Article
|
Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression.
|
|
Academic Article
|
Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant.
|
|
Academic Article
|
Kidney and pancreas transplantation at Wake Forest University Baptist Medical Center.
|
|
Academic Article
|
A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.
|
|
Academic Article
|
Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantation.
|
|
Academic Article
|
Infection after liver transplantation.
|
|
Academic Article
|
Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
|
|
Academic Article
|
A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years.
|
|
Academic Article
|
Optimal use of older donors and recipients in kidney transplantation.
|
|
Academic Article
|
Acute sensory neuropathy associated with rabbit antithymocyte globulin.
|
|
Academic Article
|
A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.
|
|
Academic Article
|
Advances in immunosuppression for pancreas transplantation.
|
|
Academic Article
|
Cadaveric renal transplantation with quadruple immunosuppression in patients with a positive antiglobulin crossmatch.
|
|
Academic Article
|
A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
|
|
Academic Article
|
Cost-effective immunosuppressive options for solid organ transplantation: a guide to lower cost for the renal transplant recipient in the USA.
|
|
Academic Article
|
Clinical operational tolerance after renal transplantation: current status and future challenges.
|
|
Academic Article
|
Gout and transplantation: new treatment option-same old drug interaction.
|
|
Academic Article
|
Withdrawal of steroid immunosuppression in renal transplant recipients.
|
|
Academic Article
|
Quadruple immunosuppressive therapy for liver transplantation.
|
|
Academic Article
|
Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation.
|
|
Academic Article
|
Preliminary experience with FK 506 in pancreas transplant recipients.
|
|
Academic Article
|
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
|
|
Academic Article
|
FK 506 induction and rescue therapy in pancreas transplant recipients.
|
|
Academic Article
|
Prevention and management of hematuria in combined pancreas-kidney transplant recipients with pancreaticoduodenocystostomy.
|
|
Academic Article
|
Experience with azathioprine withdrawal after simultaneous kidney-pancreas transplantation.
|
|
Academic Article
|
Sequential pancreas after kidney transplantation: is anti-lymphocyte induction therapy needed?
|
|
Academic Article
|
Late acute rejection episodes after vascularized pancreas transplantation.
|
|
Academic Article
|
Optimal immunosuppression in pancreas transplantation.
|
|
Academic Article
|
Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction.
|
|
Academic Article
|
Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study.
|
|
Academic Article
|
The importance of early prevention of renal dysfunction in liver transplant recipients.
|
|
Academic Article
|
Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study.
|
|
Academic Article
|
A multicenter trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: interim analysis.
|
|
Academic Article
|
Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone.
|
|
Concept
|
Immunosuppressive Agents
|
|
Academic Article
|
Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective.
|
|
Academic Article
|
5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.
|
|
Academic Article
|
Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
|
|
Academic Article
|
The search for the optimal antibody induction strategy in kidney transplantation: still "hazy" after all these years.
|
|
Academic Article
|
Delayed spontaneous hepatitis C virus elimination in a renal transplant patient following graft rejection.
|